Bills
26-5529 — Transmittal by the County Clerk of the annual financial report for Harris County Emergency Services District No. 5 for the year ending December 31, 2025.
26-5529 is a measure before a local body in Texas. This page is what Rallybase holds about it and the date each part of it was read.
Its source has published no summary of it that Rallybase holds, and Rallybase prints none it cannot attribute to a source and a date.
As of 2026-09-20, the source's own latest action on it read: "Accepted".
- Identifier
- 26-5529
- Level
- Local
- State
- Texas
- Jurisdiction identifier
- harriscountytx
- Where that identifier comes from
- harriscountytx — the Legistar jurisdiction that assigned this number. A city council has no session, so the URL carries the jurisdiction in that place instead.
- Latest action, as the source published it
- Accepted
- Read on
What you can do from here
- Open letter draftingYou write the letter; sending it yourself is free
- Every bill Rallybase is tracking
What Rallybase does not know here
- Who sponsored it. The sync that loads these rows does not carry a sponsor.
- How anybody voted on it. Rallybase has not read roll calls for this body, which is our coverage that is empty and not a statement about whether a vote was held.
- When it is next scheduled to be taken up.
Other measures in Texas
- 26-5530 — Transmittal by the County Clerk of a Publication of Notice of District Petition regarding creation of Harris County Municipal Utility District No. 613 received from the Texas Commission on Environmental Quality.
- 26-5532 — Request for approval of an office lease agreement with Gavi Westway III, LLC, in the amount of $32,198,751.52 for approximately 86,743 rentable square feet of office space located at 4425 Westway Park Boulevard, Houston, Texas 77041 (Agreement No. 2026-77).
- 26-5542 — Request for approval of a Public Health or Safety Exemption from the competitive bid requirements with Merck & Co., Inc. d/b/a Merck Sharp & Dohme LLC; GlaxoSmithKline Holdings (Americas) Inc. d/b/a GlaxoSmithKline LLC; and Sanofi Vaccines US Inc. in the amount of $1,600,000 for various vaccines for the Refugee Health Screening Program for Public Health Services for the period of October 1, 2026 - September 30, 2027 using grant funds provided by the U.S. Department of Health and Human Services R